Physician
Pathology Sciences Medical Group, PC
Pathology Sciences Medical Group, PC was paid $3.84M by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 40% of everything it billed.
33Billing provider infoPATHOLOGY SCIENCES MEDICAL GROUP, PC
NORFOLK, VA 23507
NORFOLK, VA 23507
33aNPI1366499733assigned 05/30/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$3.84M
24GClaims540,854
24DCodes billed118
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Virginia
Rank by total paid#1 of 63
Median peer was paid$6K
This provider vs. median619×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,792 | $221K | |
| 2019 | 20,217 | $481K | |
| 2020 | 40,385 | $579K | |
| 2021 | 105,797 | $721K | |
| 2022 | 101,413 | $618K | |
| 2023 | 141,607 | $650K | |
| 2024incomplete | 119,643 | $572K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 40% | 42,983 | 39,012 | $1.52M |
| 88307 | 21% | 11,901 | 11,038 | $791K | |
| 85060 | 13% | 38,852 | 33,818 | $487K | |
| 88141 | 4.7% | 10,607 | 9,127 | $182K | |
| 83020 | 4.0% | 11,954 | 10,972 | $154K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 11,187 | 4,231 | $133K |
| 88189 | 3.1% | 2,870 | 2,465 | $118K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.0% | 4,482 | 3,722 | $75K |
| 88342 | 1.8% | 3,116 | 2,728 | $70K | |
| 86334 | 1.8% | 6,866 | 6,188 | $68K | |
| 84165 | 1.2% | 6,051 | 5,407 | $45K | |
| 88377 | <1% | 384 | 284 | $32K |
106 more codes
| 88341 | <1% | 407 | $24K | |
| 88304 | <1% | 2,678 | $23K | |
| 88112 | <1% | 1,042 | $16K | |
| 85576 | <1% | 1,782 | $14K | |
| 86335 | <1% | 1,387 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 43,212 | $7K |
| 88291 | <1% | 476 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 39,486 | $5K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 2,685 | $4K |
| 88188 | <1% | 56 | $3K | |
| 84166 | <1% | 229 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,486 | $2K |
| 84484 | <1% | 12,488 | $2K | |
| 83735 | <1% | 12,098 | $2K | |
| 85027 | <1% | 15,637 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,982 | $2K |
| 88311 | <1% | 259 | $2K | |
| 88302 | <1% | 204 | $2K | |
| 82962 | <1% | 44,281 | $2K | |
| 86079 | <1% | 68 | $2K | |
| 83605 | <1% | 5,441 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,128 | $1K |
| 80076 | <1% | 10,655 | $1K | |
| 83880 | <1% | 4,261 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,135 | $1K |
| 82803 | <1% | 2,514 | $1K | |
| 81001 | <1% | 18,089 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,809 | $980.67 |
| 81241 | <1% | 438 | $980.03 | |
| 80061 | Lipid panel | <1% | 2,685 | $963.51 |
| 80047 | <1% | 5,969 | $909.27 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,761 | $868.29 |
| 83690 | <1% | 8,403 | $855.00 | |
| 88173 | <1% | 31 | $741.55 | |
| 86901 | <1% | 7,790 | $679.21 | |
| 87040 | <1% | 5,044 | $670.29 | |
| 85610 | <1% | 4,866 | $650.42 | |
| 84703 | <1% | 7,107 | $641.16 | |
| 87210 | <1% | 3,414 | $629.20 | |
| 81240 | <1% | 410 | $555.38 | |
| 80202 | <1% | 1,306 | $490.24 | |
| 84100 | <1% | 4,208 | $484.25 | |
| 87077 | <1% | 3,437 | $480.93 | |
| 85730 | <1% | 2,383 | $452.01 | |
| 82728 | <1% | 932 | $442.04 | |
| 82565 | <1% | 3,577 | $381.02 | |
| 82607 | <1% | 917 | $377.66 | |
| 86078 | <1% | 14 | $366.21 | |
| 85379 | <1% | 4,169 | $353.81 | |
| 86923 | <1% | 979 | $312.00 | |
| 82397 | <1% | 1,726 | $301.31 | |
| 82330 | <1% | 1,385 | $300.94 | |
| 87186 | <1% | 2,231 | $296.45 | |
| 85014 | <1% | 7,273 | $273.58 | |
| 81243 | <1% | 212 | $264.25 | |
| 86900 | <1% | 7,582 | $261.51 | |
| 81003 | <1% | 5,470 | $253.63 | |
| 83615 | <1% | 1,995 | $251.96 | |
| 83550 | <1% | 1,026 | $249.84 | |
| 87081 | <1% | 2,913 | $244.27 | |
| 84702 | <1% | 2,201 | $243.65 | |
| 84030 | <1% | 2,573 | $206.84 | |
| 88369 | <1% | 20 | $201.55 | |
| 83540 | <1% | 1,031 | $199.92 | |
| 87070 | <1% | 1,425 | $189.30 | |
| 82310 | <1% | 1,667 | $180.27 | |
| 86850 | <1% | 4,491 | $176.78 | |
| 84439 | <1% | 567 | $165.32 | |
| 82746 | <1% | 502 | $163.56 | |
| 85018 | <1% | 4,448 | $160.93 | |
| 84550 | <1% | 1,319 | $151.15 | |
| 87205 | <1% | 1,501 | $138.99 | |
| 82248 | <1% | 747 | $136.04 | |
| 87493 | <1% | 32 | $130.00 | |
| 84132 | <1% | 1,442 | $112.24 | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 40 | $106.30 |
| 82550 | <1% | 807 | $98.82 | |
| 86140 | <1% | 658 | $84.51 | |
| 82570 | <1% | 792 | $82.58 | |
| 84460 | <1% | 807 | $81.67 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $81.00 |
| 84520 | <1% | 1,033 | $80.92 | |
| 81025 | <1% | 6,667 | $68.11 | |
| 88720 | <1% | 3,802 | $65.99 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 292 | $57.20 |
| 85045 | <1% | 619 | $48.86 | |
| 84450 | <1% | 811 | $47.99 | |
| 87340 | <1% | 74 | $42.88 | |
| 85652 | <1% | 498 | $39.34 | |
| 82247 | <1% | 170 | $25.10 | |
| 84156 | <1% | 595 | $14.68 | |
| 87449 | <1% | 21 | $13.86 | |
| 82140 | <1% | 168 | $6.63 | |
| 87075 | <1% | 100 | $3.51 | |
| 86880 | <1% | 88 | $2.46 | |
| 85384 | <1% | 26 | $1.27 | |
| 82055 | 0% | 412 | $0.00 | |
| 80101 | 0% | 72 | $0.00 | |
| 81329 | 0% | 178 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 15 | $0.00 |
| 85520 | 0% | 96 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 26 | $0.00 |
| 0240U | 0% | 68 | $0.00 | |
| 83520 | 0% | 27 | $0.00 | |
| 80069 | 0% | 16 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAHHAN, HASSAN (VICE PRESIDENT)